Other languages Quanterix Corporation

Equities

QTRX

US74766Q1013

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
15.56 ^USD	-0.19%		-1.71%	-43.09%

Apr. 12	Quanterix Corporation Announces Laurie Olson, Director Will Not Stand for Re-Election	CI
Mar. 25	Transcript : Quanterix Corporation - Special Call

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Quanterix Corporation Announces Laurie Olson, Director Will Not Stand for Re-Election	Apr. 12
Quanterix Corporation Receives Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer?s Disease	Mar. 04
Quanterix Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29
Quanterix Corporation Provides Earnings Guidance for the Year 2024	Feb. 29
Quanterix Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29
Quanterix Corporation Reaffirms Earnings Guidance for the Year 2023	Feb. 26
Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer?S Disease	Feb. 26
Quanterix Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06
Quanterix Corporation Revises Earnings Guidance for the 2023	Nov. 06
Quanterix Launches High Accuracy P-Tau 217 Blood Biomarker Test to Aid Physician Diagnosis of Alzheimer's Disease	23-10-24
Quanterix Signs License Deal for Johnson & Johnson's p-Tau 217 Antibodies, Assay Designs	23-10-24
Blood tests needed for widespread Alzheimer's diagnosis on the way	23-10-11
Insider Buy: Quanterix	23-09-11
Quanterix Corporation Appoints William P. Donnelly to its Board of Directors	23-08-21
Quanterix Names Vandana Sriram as Finance Chief	23-08-09
Quanterix Corporation Announces Michael Doyle Cease Serving as Treasurer, Effective August 21, 2023	23-08-09
Quanterix Corporation Provides Earnings Guidance for the Full-Year 2023	23-08-07
Quanterix Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07
Quanterix Introduces Test to Help Evaluation of Patients With Alzheimer's Disease	23-07-06
Quanterix Corporation Launches LucentAD Biomarker Blood Test to Aid Physician Diagnosis of Alzheimer's Disease in Patients	23-07-06

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Quanterix Corporation

Equities

QTRX

US74766Q1013

Other languages

Filters